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E d i t o r i a l
It’s randomized and double blinded . . . 
what more do we want?
John R. W. Kestle, M .D.
Division of Pediatric Neurosurgery, Primary Children’s Medical 
Center, Salt Lake City, Utah
This issue o f  Jou rn al o f  N eurosurgery: P ed ia trics  pre­
sents a random ized trial in w h ich  investigators have evalu­
ated antimicrobial suture (A M S ) in the prevention o f  shunt 
infection. The authors random ized 84 shunt procedures in 
61 patients over 21 m onths. T he surgeons and patients w ere  
blinded to treatment group. The groups appeared to be bal­
anced w ith respect to shunt infection risk factors. Infection  
w ithin 6 m onths o f  surgery occurred in 2  (4.3% ) o f  4 6  A M S  
procedures and in 8 (21% ) o f  38 control procedures.
T his study is  a good  first step. T he authors should b e ap­
plauded for conducting a double-blinded random ized trial, 
but the results need to be considered preliminary, and as 
they stand are not sufficient for a change in practice. A s the 
authors state, they need  further evaluation in a larger ran­
dom ized  trial.
W hy? W hat m ore do w e  need before w e  adopt A M S s for 
shunt surgery? There are a num ber o f  issues that should be  
addressed in a defin itive trial. T he authors appropriately 
recogn ize som e o f  these in their manuscript. I w ou ld  like to 
highlight them.
1) T he infection rate in the control group in the study w as 
high (21% ). This is a function o f  a sm all sam ple size. With 
only  38 patients in the control group, 1 or 2  events w ill have  
a large im pact on the results. If the infection rate in the con­
trol group had been closer to  their usual (9% ), a m uch larg­
er sam ple size  (1062  patients) w ould  have been required. 
T his issue can certainly b e addressed in a larger trial.
2 ) A  study hypothesis should b e  defined ahead o f  time. It 
should specify  the difference that the investigators are in­
terested in detecting (that is, cutting their infection rate in 
h a lf or by  x% ) and have adequate pow er to detect the sm all­
est difference that is c lin ically  important. This m ay have  
been done, but it w as not described in the report. A s a result 
it appears that the authors kept random izing patients until 
they got a “significant” difference.
3) Patients w ere “rerandom ized.” In this case the number 
w as sm all and it is unlikely to have a large im pact on the re­
sults, but I w ould  advise against this in the definitive trial. 
T he analysis assum es that each patient entered is indepen­
dent, and this is not true w hen patients are random ized more 
than once.
4 ) T he technique o f  cerebrospinal flu id  (C SF) culture 
w as not described. W ere cases a lw ays kept long enough to 
identify P ropion ibacteriu m  a c n e s l
5) B ecause the outcom e (positive culture) is dependent 
on the results o f  a shunt tap, the indications for doing a tap 
should b e clearly defined.
6) T hey report an interim analysis. A t the first interim an­
alysis the results w ere “not significant,” so  they continued  
accrual. A t the tim e o f  a second interim analysis there w as 
a significantly higher infection rate in the control group, and 
new  patient enrollm ent w as halted. I find  this puzzling. A n  
interim analysis in a clin ical trial affects the sam ple size, and 
there are w ell-defined  techniques for doing th is.1 U sually  
the results have to b e extrem e to justify  early stopping— so  
extrem e that the investigators (or m ore com m only an inde­
pendent data safety m onitoring board) fee l uncom fortable 
random izing any m ore patients to the control arm o f  the 
study. Apparently the authors felt this w ay and stopped the 
study, and yet they are now  proposing another larger trial. In 
light o f  these results and their decision  to stop, can they ran­
dom ize patients in the future and convince others to do so?
7) “Patient population characteristics did not differ sig ­
nificantly. . . .” A s so  m any authors do, this paper includes 
probability values beside each o f  the baseline parameters to 
test random ization. T hese values g ive  the probability that 
the observation occurred by  chance. In a random ized trial, 
the observation (distribution o f  baseline parameters betw een  
the groups) w as due to chance, by  definition. A ll probability 
values are 1.0. In addition, there is no pow er calculation for  
such a test, so  a “nonsignificant” probability value is m ean­
ingless. T he table is appropriate (the probability values are 
not). Factors that appeal' to  be im balanced should b e evalu­
ated based on their clin ical importance, and if  an important 
im balance exists it should be addressed in the analysis.
Overall I am delighted to see this paper: w e  need more like 
this! I congratulate the authors on a w ell-done pilot study, but 
w e cannot use this paper to justify  the use o f  A M S s in shunt 
surgeiy. I agree w ith the authors that w e  m ust use their work  
to plan a definitive trial.
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W e appreciate Dr. K estle’s thoughtful analysis, kind re­
marks, and constructive critique o f  our sm all single-center 
trial. W e do not cla im  to present a definitive study, m erely to 
report interesting and potentially beneficial findings related 
to the problem  o f  shunt infection. It is our hope that these 
findings w ill generate sufficient interest w ithin the pediatric 
neurosurgical com m unity for the definitive study to be d e­
signed, im plem ented, and com pleted.
A s stated, som e issues w ere elucidated in  our manuscript. 
The com m on them e for these is  that com prom ises w ere 
m ade to accrue procedures quickly from  a relatively m od­
est-sized  pediatric neurosurgical service. W e offer the fo l­
low in g  com m ents to am plify and further explain these is­
sues.
1) The control group infection rate w as higher than our 
institutional “baseline.” Continuing the study at a single cen ­
ter, how ever, w ould  have taken a prohibitive am ount o f  tim e 
to accrue >  1000 procedures.
2 ) W ith this lim itation in  m ind, the study w as initiated  
w ithout pow er calculations. E very conservative pow er esti­
m ate generated beforehand indicated that the trial could not 
be com pleted  in  <  5 years. The study design  w as kept sim ­
p le and inexpensive to m in im ize the “investm ent.”
3) T he decision  to “rerandom ize” patients w as m ade to 
enroll as m any shunt procedures as p ossib le, accepting that 
this design  aspect is  less than ideal.
4 ) T he m icrob iology laboratory at our institution has 
standing orders to m onitor all C SF  cultures from  shunts for 
P. acnes, and all C SF  shunt aspirates are sent for aerobic 
and anaerobic cultures.
5) A t our institution all patients w ith  shunts w h o  present 
w ith sym ptom s/signs o f  shunt m alfunction and/or shunt in­
fection  w ithin 6 m onths o f  any operative shunt procedure 
undergo shunt tapping to rule out infection.
6) After 4 0  procedures had been randomized and the pa­
tients fo llow ed  for 6 m onths, the control group had 4  in­
fections and the A M S group had none. This difference y ield ­
ed a right-tailed probability value o f  exactly 0.05; m erely a 
trend. Random ization continued until the results reported 
w ere observed, although not all patients had reached 6 
m onths postprocedure. A t that point enrollment w as halted 
and no additional infections w ere detected. W e w ere uncom ­
fortable random izing m ore patients primarily because the 
control group’s infection rate w as so  high. W e believe a larg­
er trial is necessary and appropriate due to the study limita­
tions previously enumerated.
7) W e stand corrected. L esson  learned.
In conclusion , w e  w ould  be delighted to collaborate w ith  
Dr. K estle and others w ho w ould  b e w illin g  to participate 
in  a defin itive trial. (D O I: 1 0 .3 1 7 1 /P E D /2008 /2 /8 /109 )
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